Aurora Spine CorporationASG.V
Health Care · Health Care Equipment & Services · TSX-V · Canada · aurora-spine.com
Aurora Spine Corporation develops and distributes minimally invasive spinal implants and fusion devices for the treatment of degenerative disc disease and spinal conditions. The company's product portfolio includes interspinous process lumbar fusion systems (ZIP series), titanium-coated interbody cages, and DEXA Technology-based implants for lumbar and cervical procedures. It trades on the TSXV and OTCQB markets.
Key ratios
Operating cash flow growth
-32.3%TTM
2025
-13.3%
FCF / Sales
1.0%TTM
2025
2.2%2024
3.7%2023
-9.7%2022
-15.7%
Net margin
-7.0%TTM
2025
-4.0%2024
-5.7%2023
-11.6%2022
-10.1%
ROA
-6.2%TTM
2025
-2.6%2024
-3.7%2023
-8.5%2022
-8.1%
ROE
-36.0%TTM
2025
-17.8%2024
-20.7%2023
-35.0%2022
-30.4%
Revenue growth
-4.6%TTM
2025
4.6%2024
21.0%2023
-2.4%
Recent news
Aurora Spine Corporation Announces Second Quarter FY26 Financial Results
Aurora Spine Announces Settlement of Arbitration, New Patent License Agreement for SI Joint Product and Increase in Funding from Insider
Aurora Spine and CornerLoc Announce Strategic Commercial Alliance to Expand Minimally Invasive Spine and SI Joint Solutions Nationwide
Aurora Spine Corporation Announces First Quarter FY26 Financial Results
Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants
Aurora Spine Corporation Announces Record Fourth Quarter and FY25 Financial Results
Aurora Spine Announces Issuance of Two U.S. Patents
Track ASG.V in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer